Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies

REFERENCES

1. 1.↵
   2. Carelli V,
   3. Ross-Cisneros FN,
   4. Sadun AA

   . Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004;23:53–89

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Yu-Wai-Man P,
   3. Griffiths PG,
   4. Chinnery PF

   . Mitochondrial optic neuropathies: disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011;30:81–114

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Sadun AA,
   3. Win PH,
   4. Ross-Cisneros FN, et al

   . Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000;98:223–32

   PubMed
4. 4.↵
   2. Pan BX,
   3. Ross-Cisneros FN,
   4. Carelli V, et al

   . Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2012;53:7608–17

   Abstract/FREE Full Text
5. 5.↵
   2. Barcella V,
   3. Rocca MA,
   4. Bianchi-Marzoli S, et al

   . Evidence for retrochiasmatic tissue loss in Leber's hereditary optic neuropathy. Hum Brain Mapp 2010;31:1900–06

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Rizzo G,
   3. Tozer KR,
   4. Tonon C, et al

   . Secondary post-geniculate involvement in Leber's hereditary optic neuropathy. PLoS One 2012;7:e50230

   CrossRefPubMed
7. 7.↵
   2. Milesi J,
   3. Rocca MA,
   4. Bianchi-Marzoli S, et al

   . Patterns of white matter diffusivity abnormalities in Leber's hereditary optic neuropathy: a tract-based spatial statistics study. J Neurol 2012;259:1801–07

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Bette S,
   3. Schlaszus H,
   4. Wissinger B, et al

   . OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain. Acta Neuropathol 2005;109:393–99

   CrossRefPubMed
9. 9.↵
   2. Yu-Wai-Man P,
   3. Griffiths PG,
   4. Gorman GS, et al

   . Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010;133:771–86

   Abstract/FREE Full Text
10. 10.↵
    2. Pierpaoli C,
    3. Jezzard P,
    4. Basser PJ, et al

    . Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637–48

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Winkler A,
    3. Ridgway G,
    4. Webster M, et al

    . Permutation inference for the general linear model. Neuroimage 2014;92:381–97

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Nucifora PG,
    3. Verma R,
    4. Lee SK, et al

    . Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007;245:367–84

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Mori S,
    3. Wakana S,
    4. van Zijl PC, et al

    . MRI Atlas of Human White Matter. Amsterdam: Elsevier; 2005
14. 14.↵
    2. Hua K,
    3. Zhang J,
    4. Wakana S, et al

    . Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 2008;39:336–47

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Eickhoff SB,
    3. Stephan KE,
    4. Mohlberg H, et al

    . A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 2005;25:1325–35

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Bach M,
    3. Laun FB,
    4. Leemans A, et al

    . Methodological considerations on tract-based spatial statistics (TBSS). Neuroimage 2014;100:358–69

    CrossRefPubMed
17. 17.↵
    2. Barboni P,
    3. Savini G,
    4. Parisi V, et al

    . Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age. Ophthalmology 2011;118:2076–80

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Mondelli M,
    3. Rossi A,
    4. Scarpini C, et al

    . BAEP changes in Leber's hereditary optic neuropathy—further confirmation of multisystem involvement. Acta Neurol Scand 1990;81:349–53

    PubMedWeb of Science
19. 19.↵
    2. Ceranić B,
    3. Luxon LM

    . Progressive auditory neuropathy in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2004;75:626–30

    Abstract/FREE Full Text
20. 20.↵
    2. Yu-Wai-Man P,
    3. Elliot C,
    4. Griffiths PG, et al

    . Investigation of auditory dysfunction in Leber hereditary optic neuropathy. Acta Ophthalmol 2008;86:630–33

    CrossRefPubMed
21. 21.↵
    2. Rance G,
    3. Kearns LS,
    4. Tan J, et al

    . Auditory function in individuals within Leber's hereditary optic neuropathy pedigrees. J Neurol 2012;259:542–50

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Cortelli P,
    3. Montagna P,
    4. Avoni P, et al

    . Leber's hereditary optic neuropathy: genetic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology 1991;41:1211–15

    CrossRefPubMed
23. 23.↵
    2. Inglese M,
    3. Rovaris M,
    4. Bianchi S, et al

    . Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2001;70:444–49

    Abstract/FREE Full Text
24. 24.↵
    2. Harding AE,
    3. Sweeney MG,
    4. Miller DH, et al

    . Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979–89

    Abstract/FREE Full Text
25. 25.↵
    2. Carelli V,
    3. Bellan M

    . Myelin, mitochondria, and autoimmunity: what's the connection? Neurology 2008;70:1075–76

    CrossRefPubMed
26. 26.↵
    2. Klopstock T,
    3. Yu-Wai-Man P,
    4. Dimitriadis K, et al

    . A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 2011;134:2677–86

    Abstract/FREE Full Text
27. 27.↵
    2. Carelli V,
    3. La Morgia C,
    4. Valentino ML, et al

    . Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011;134:e188

    FREE Full Text
28. 28.↵
    2. Hudson G,
    3. Amati-Bonneau P,
    4. Blakely EL, et al

    . Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;131:329–37

    Abstract/FREE Full Text
29. 29.↵
    2. Amati-Bonneau P,
    3. Valentino ML,
    4. Reynier P, et al

    . OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain 2008;131:338–51

    Abstract/FREE Full Text
30. 30.↵
    2. Verny C,
    3. Loiseau D,
    4. Scherer C, et al

    . Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology 2008;70:1152–53

    CrossRefPubMed
31. 31.↵
    2. Liskova P,
    3. Ulmanova O,
    4. Tesina P, et al

    . Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol 2013;91:e225–31

    CrossRef
32. 32.↵
    2. Milone M,
    3. Younge BR,
    4. Wang J, et al

    . Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 2009;9:279–81

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Baker MR,
    3. Fisher KM,
    4. Whittaker RG, et al

    . Subclinical multisystem neurologic disease in “pure” OPA1 autosomal dominant optic atrophy. Neurology 2011;77:1309–12

    CrossRefPubMed
34. 34.↵
    2. Zanna C,
    3. Ghelli A,
    4. Porcelli AM, et al

    . OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008;131:352–67

    Abstract/FREE Full Text
35. 35.↵
    2. Koene S,
    3. Rodenburg RJ,
    4. van der Knaap MS, et al

    . Natural disease course and genotype-phenotype correlations in complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 2012;35:737–47

    CrossRefPubMed
36. 36.↵
    2. Morelli A,
    3. Ravera S,
    4. Panfoli I

    . Hypothesis of an energetic function for myelin. Cell Biochem Biophys 2011;61:179–87

    CrossRefPubMed
37. 37.↵
    2. Barboni P,
    3. Carbonelli M,
    4. Savini G, et al

    . OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Ophthalmology 2010;117:1547–53

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Frezza C,
    3. Cipolat S,
    4. Martins de Brito O, et al

    . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006;126:177–89

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Cipolat S,
    3. Rudka T,
    4. Hartmann D, et al

    . Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 2006;126:163–75

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Barboni P,
    3. Valentino ML,
    4. La Morgia C, et al

    . Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. Brain 2013;136:e231

    FREE Full Text